Xos, Inc. Form 8-K Summary
Reporting date: June 22, 2023; filed June 23, 2023. The filing reports amendments to financing arrangements with Yorkville and does not include financial statements or operating results.
Business Context and Reporting Period
Xos, Inc. is a Delaware corporation headquartered in Los Angeles, California. Its common stock and warrants trade on Nasdaq under the symbols XOS and XOSWW, respectively. The company identifies as an emerging growth company.
Material Financing Changes
- Standby Equity Purchase Agreement: The company amended its March 23, 2022 SEPA with Yorkville, which permits Xos to request purchases of up to $125.0 million of common stock, subject to conditions.
- The purchase price for an Option 1 Advance will now be based on the lowest VWAP during the applicable three-day pricing period, rather than an average of the lowest daily VWAPs.
- Advance requests will be denominated in shares instead of dollars.
- Yorkville’s beneficial ownership limitation increased from 4.99% to 9.99%, subject to provisions addressing convertible securities and ownership calculations.
- The SEPA Commitment Period was extended to February 11, 2026.
- Convertible debentures: The company and Yorkville amended the August 9, 2022 securities purchase agreement and related convertible debentures, which provide for up to $35.0 million of convertible debentures, subject to conditions and limitations.
- A side letter removes a restriction on the company’s ability to make SEPA advances, but preserves specified limitations while principal or interest remains outstanding under the debentures.
- SEPA advance proceeds are generally applied as optional redemptions against amounts outstanding under the convertible debentures. For monthly cumulative reductions exceeding $3.0 million, 75% of excess proceeds is paid to the company and 25% is applied to optional redemption.
- The parties also amended the definition of “Primary Market” in the convertible debentures.
Financial Metrics, Liquidity, and Debt
- The filing provides no revenue, profit, cash flow, margin, balance-sheet, or liquidity figures.
- Available financing capacity disclosed includes up to $125.0 million under the SEPA and up to $35.0 million in convertible debentures; the filing does not state how much remains available or outstanding as of June 22, 2023.
- The arrangements may provide additional equity funding but may also result in share issuance and dilution.
Outlook, Risks, and Unusual Items
- The amendments facilitate potential equity advances through February 11, 2026, but the SEPA remains a right, not an obligation, for the company and is subject to conditions.
- Yorkville’s increased ownership limit and the change to share-denominated advances may affect the timing, size, and potential dilution of future issuances.
- Advance proceeds may be required to reduce outstanding convertible-debt obligations, limiting the portion of proceeds available for corporate purposes.
- The filing does not provide management guidance, an operating outlook, or quantified risk commentary.
Investor Verification Items
- Verify the full SEPA Amendment, side letter, and convertible debenture amendment filed as Exhibits 10.1 through 10.3.
- Confirm the outstanding principal and accrued interest under the convertible debentures and the remaining SEPA availability.
- Review subsequent filings for actual advances, share issuances, conversions, redemptions, and resulting dilution.
- Assess the contractual conditions governing advances and the interaction between SEPA proceeds and debenture redemptions.